Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study [Phase 3]
Phase 3 study (StepByStep) evaluating a mobile health and social media–based physical activity intervention in adolescent and young adult ch…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for IN10018 in combination with RNK08954 for KRASG12D mutation-positive locally advanced or metastatic solid tumors; t…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors [Phase 1]
This document notes a Phase 1 trial of BL-M24D1 in patients with gastrointestinal tumors and other solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies [Phase 1]
Phase 1 clinical trial update indicating COM503 is being studied in participants with advanced solid tumors, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer [NA]
This clinical trial update outlines a study evaluating immunological mechanisms and biomarkers related to immunotherapy in patients with ear…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
This update describes a long-term follow-up study for participants treated with Kite-sponsored gene-modified cell therapies, with enrollment…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer [Phase 1]
This clinical trial update announces the first-in-human, Phase 1 study of ATX-295, an oral inhibitor of KIF18A, in patients with advanced or…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours [Phase 1]
This update outlines a Phase 1 study to assess how Rifampicin affects the pharmacokinetics of multiple doses of Cediranib in patients with s…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: SLV-324 Treatment of Metastatic Solid Tumors [Phase 1]
SLV-324 is being studied in a Phase 1 trial for metastatic solid tumors, and recruitment is ongoing. The sponsor is Solve Therapeutics.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating GVV858 as a single agent or in combination with endocrine therapy for hormone receptor-positiv…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) [Phase 1, Phase 2]
AVZO-1418 is being studied as a single agent and in combination therapy for locally advanced or metastatic solid tumors in a Phase 1/2 trial…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation [Phase 1, Phase 2]
Clinical trial update for ARV-806 evaluating KRAS G12D-mutant advanced solid tumors in adults; Phase 1/2, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002) [Phase 1, Phase 2]
This clinical trial update indicates that MK-3120 is being evaluated for safety and efficacy in participants with advanced solid tumors in a…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A First in Human Study of PLT012 in Participants With Solid Tumor Cancers [Phase 1]
This is a first-in-human Phase 1 study of PLT012 in participants with solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of KSQ-001EX, autologous tumor infiltrating lymphocytes engineered to inactivate SOCS1, being evaluated in select advanced s…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies [Phase 1]
This clinical trial update describes a Phase 1/1B study of ST-01156, a small-molecule RBM39 degrader, in patients with advanced solid tumors…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical study evaluating SYS6043 for advanced/metastatic solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk [NA]
Clinical trial update NCT06051214 evaluating thrombin generation as a predictor of thromboembolic events in oncology patients at risk; curre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection [Phase 2]
Phase 2 clinical trial evaluating donor CMV-specific cytotoxic T lymphocytes for persistent cytomegalovirus infection in patients with hemat…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
This clinical trial update describes a Phase 1 study of XB371 in participants with locally advanced or metastatic solid tumors, currently re…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors [Phase 1, Phase 2]
Nous-209 genetic vaccine trial for microsatellite instability-high solid tumors is in Phase 1/Phase 2 and not currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study evaluating PEP08 in MTAP-deleted advanced or metastatic solid tumors is currently recruiting. The sponsor is PharmaEngine.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
The study investigates cachexia frequency in ambulatory cancer patients and the psychological burden on patients and their primary caregiver…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors [Phase 1]
This document provides an update on a Phase 1 trial evaluating BNT317 for advanced solid tumors. It discusses safety and early signals of ef…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis
This clinical trial update describes a planned network meta-analysis comparing different olanzapine dose regimens for preventing chemotherap…